CIK 0001640266
- Accelerated filer
- Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 72 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-06 | Ferguson Toby Chief Medical Officer | Grant or award | +45,000 | 183,914 | ||
| 2026-02-06 | Ferguson Toby Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +210,000 | 210,000 | ||
| 2025-08-18 | Ferguson Toby Chief Medical Officer | Sale | −19,000 | $3.73 | $71K | 138,914 |
| 2025-04-02 | Ferguson Toby Chief Medical Officer | Sale | −10,086 | $3.43 | $35K | 157,914 |
| 2025-02-21 | Ferguson Toby Chief Medical Officer | Grant or award | +63,000 | 168,000 | ||
| 2025-02-21 | Ferguson Toby Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +126,000 | 126,000 | ||
| 2024-04-01 | Ferguson Toby Chief Medical Officer | Grant or award | +105,000 | 105,000 | ||
| 2024-03-25 | Ferguson Toby Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +210,000 | 210,000 |
Page 1 of 1 · 8 trades